AstraZeneca innovator joins IDEA Pharma

IDEA Pharma is delighted to announce the recent appointment of Michael Morgan-Curran to its ever-increasing ranks.

Michael Morgan-Curran

Michael joins the company as a key member of the core strategic delivery team, tasked with shaping and leading new approaches to help clients make better decisions for products across a variety of therapeutic areas.

“At IDEA we garner the very best intellectual, creative and innovative minds that span our industry, pushing us at the forefront of transformational strategic development at Phase II, and Michael’s appointment only further strengthens our position,” comments Mike Rea, IDEA’s CEO. “With an exemplary international working background and his professional, considered and charismatic approach to client delivery, he is already proving to be a valid member of our team.”

Michael has 22 years’ experience working in the pharmaceutical and consultancy industry; commenting on his appointment he said: “My career to date has been built on spearheading innovation within many commercial organisations, so it makes complete sense to join IDEA, a company that is clearly leading the industry in ensuring innovative drugs get to market. I look forward to tackling the challenges that lay ahead.”